Family: | Direxion Shares |
Name: | Direxion Daily Pharmaceutical & Medical Bull 3X Shares |
Inception Date: | 15-Nov-2017 |
Termination Date: | |
Investment Objective: | The Direxion Daily Pharmaceutical & Medical Bull 3X Shares seek daily investment results, before fees and expenses of 300% of the performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the Global Industry Classification Standard (GICS) pharmaceuticals sub-industry. To be eligible for inclusion in the Index, stocks must satisfy one of the following combined size and liquidity criteria: (1) have a float-adjusted market capitalization above $300 million with a float-adjusted liquidity ratio (defined by dollar value traded over the previous 12 months divided by the float-adjusted market capitalization as of the Index rebalancing reference date) above 50%; (2) have a float-adjusted market capitalization above $500 million with a float-adjusted liquidity ratio above 90%; or (3) have a float-adjusted market capitalization above $400 million with a float-adjusted liquidity ratio above 150%. The Index is rebalanced quarterly. |
Prospectus | |
Top 10 Holdings | ||
Derivatives offset | -201.7000% | |
S&P PHARMACEUTICALS SELECT INDEX SWAP | 91.9870% | |
S&P PHARMACEUTICALS SELECT INDEX SWAP | 70.1455% | |
S&P PHARMACEUTICALS SELECT INDEX SWAP | 39.5674% | |
GOLDMAN FINL SQ TRSRY INST 506 | 18.3028% | |
DREYFUS GOVT CASH MAN INS | 17.2267% | |
GOLDMAN SACHS FIN GOV 465 INSTITUT | X9USDGLDS | 5.4358% |
CORCEPT THERAPEUTICS INC | CORT | 3.0129% |
TARSUS PHARMACEUTICALS INC | TARS | 2.5571% |
ROYALTY PHARMA PLC- CL A | RPRX | 2.5135% |
Top 10 Holdings Weight: | 49.0% |
Number of Holdings: | 49 |
Shares Outstanding: | 2,400,001 |
Total Net Assets: | 10,368,000 |
NAV: | 4.33 |
Net Expense Ratio: | 0.95% |
Asset Class: | Equities (Stocks) |
Developed or Emerging: | Developed Market Funds |
Country: | US |
Region: | |
Strategy: | NYSE Intellidex proprietary model |
Currency: | |
Commodity: | |
Sector: | Healthcare |
Industry: | Pharmaceuticals |
Dividend Type: | |
Tax Exempt State: | |
Maturity Duration: | |
Market Cap: | Broad Market / Multi-Cap |
Credit Quality: | |
Mortgage Bond Types: | |
Bond Type: | |
Gov't Bond Types: | |
Reit Type: | |
Leverage Direction/Factor: | Leveraged (3x) |
Is Currency Hedged: | No |
US or Ex-US: | Domestic |